Fulgent Genetics agrees to buy StrataDx and assets from Bako Diagnostics for $55.5 million. Learn how this cash deal expands ...

The deal includes outreach laboratory services in 13 states. CHS will continue to operate its inpatient and emergency department labs along with other hospital-based testing services. Like its chief ...

The move adds Labcorp’s US biocompatibility, analytical testing, and preclinical research services to Namsa’s operations.

El Monte-based lab testing and pharmaceutical company Fulgent Genetics Inc. last month simultaneously announced a pair of ...

Quest Diagnostics completed its acquisition of select assets from Fresenius Medical Care’s laboratory business. As part of the transaction, the Secaucus-based testing provider will now offer ...

Franklin, Tenn.-based Community Health Systems has completed the sale of select ambulatory outreach laboratory assets to Labcorp for $194 million in cash. The deal includes certain assets of ...

Philadelphia-based Jefferson Health is offloading select assets of its outreach laboratory services to Labcorp, but will continue to own and operate its existing hospital labs for outpatient and ...

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Community Health Systems on Tuesday sold some of its ...

Quest Diagnostics plans to acquire the majority of outreach laboratory assets from OhioHealth. Under the definitive agreement announced Wednesday, Quest will purchase 90% of OhioHealth's outreach ...

SAN ANTONIO, Texas--(BUSINESS WIRE)-- bioAffinity Technologies, Inc. (Nasdaq: BIAF, BIAFW), a biotechnology company addressing the need for noninvasive detection of early-stage lung cancer, announces ...

Lab testing giant Quest Diagnostics has won bankruptcy court approval to buy certain assets of True Health Diagnostics LLC, the blood-testing company that has been operating a laboratory in downtown ...

Community Health Systems on Tuesday sold some of its ambulatory outpatient laboratory services to Labcorp for approximately $194 million in cash before transaction expenses. The deal includes assets ...